Skip to content

Human Questions

What is bioconservatism?

Bioconservatism is the view that human enhancement technologies — genetic engineering, cognitive enhancement, radical life extension — threaten human dignity and should be resisted or strictly limited.

Quick Answer

Bioconservatism is the family of views that oppose the use of technology to enhance human capacities beyond normal limits, on grounds of human dignity, the meaning of human nature, or the risks of unforeseen consequences. Its leading voices — Leon Kass, Francis Fukuyama, Michael Sandel — argue that enhancement would corrode what makes life and human community valuable. Transhumanists like Nick Bostrom call it a dangerous pessimism about the human future.

bioconservatismbioethicstranshumanismhuman-dignityenhancement

Key Takeaways

  • Bioconservatism opposes enhancement technologies as threats to dignity and human nature.
  • Key arguments: the "wisdom of repugnance," the gift of life, and the danger of a posthuman future.
  • Leading figures include Leon Kass, Francis Fukuyama, and Michael Sandel.
  • It is not anti-technology: it targets enhancement, not medicine or basic research.
  • The debate with transhumanism frames the ethics of AI, genetics, and longevity.

What Is Bioconservatism?

What Is Bioconservatism?

Bioconservatism is the position that human enhancement — genetic engineering to improve offspring, cognitive enhancers, radical life extension, and related technologies — is not simply risky but wrong, or at least deeply corrosive, and should be resisted. The name was coined by transhumanists to label their opponents, but the position has serious philosophical roots. Bioconservatives do not oppose technology or medicine; they draw a line between healing and enhancing, and argue that crossing it threatens human dignity, the meaning of human nature, and the social bonds that depend on our shared, given condition. Where transhumanists see enhancement as liberation and progress, bioconservatives see the quiet abandonment of what makes life worth living.

Historical Background

The debate took shape in the 1990s and 2000s as biotechnology made enhancement plausible. Leon Kass, who chaired the US President's Council on Bioethics under George W. Bush, argued that we should trust our "wisdom of repugnance" — the deep discomfort we feel at cloning, embryo selection, and other interventions is a moral signal, not mere prejudice. Francis Fukuyama's "Our Posthuman Future" (2002) warned that enhancement could destroy "Factor X," the undefined something that grounds equal human dignity, and produce a political nightmare of enhanced elites. Michael Sandel's "The Case Against Perfection" (2007) argued that enhancement erodes the "giftedness" of life — the acceptance of what is not our doing — which he saw as the root of humility and solidarity. Transhumanists responded that bioconservatism sentimentalizes suffering and blocks the relief of genuine human misery.

Key Concepts

  • Human dignity. The claim that our dignity rests on our given nature, and that redesigning that nature degrades it — the core bioconservative idea.
  • The wisdom of repugnance. Kass's argument that moral repugnance can be a legitimate guide, especially where the harms of a new technology are diffuse and hard to specify.
  • The gift of life. Sandel: a healthy moral life involves accepting what we did not choose — talents, limits, mortality — and enhancement turns life into an artifact, eroding humility and solidarity.
  • The posthuman danger. Fukuyama: enhancement could produce beings (or a caste of enhanced humans) whose capacities undermine the equality that liberal democracy assumes.
  • The slippery slope. Allowing "therapeutic" uses of enhancement technologies will lead, predictably, to "lifestyle" and "competitive" uses.
  • The transhumanist reply. Bostrom: suffering and premature death are the real threats to dignity; "playing God" is what medicine has always done, to everyone's benefit.

Contemporary Relevance

Bioconservatism is the standing opposition to the most consequential technologies of our time. It frames debates over CRISPR editing of human embryos, the regulation of cognitive enhancers, the funding of longevity research, and the ethics of brain-computer interfaces. It also shadows AI: if the concern about AI is that it will create beings beyond or beneath the human, bioconservatism supplies the vocabulary of dignity, limits, and the value of the given. Its critics say it is a luxury pessimism of the comfortable — that those who oppose enhancement are typically healthy, young, and secure. Its defenders reply that exactly such people can see most clearly what is being risked. Whatever one concludes, bioconservatism guarantees that the future of human enhancement will be a public argument, not a quiet technical decision.

Bioconservatism has an uncomfortable advantage in public debate: its warnings are untestable until it is too late. If enhancement corrupts human dignity, we will not know until generations have been shaped by it; if transhumanists are right, we will not know what we lost until we have lived without the limits they dismiss. This asymmetry gives the conservative position a serious dialectical strength, and its proponents are right to insist the burden of proof lies with those who would change the human condition.

Its weakness is equally real. The history of moral panic about technology — anesthesia, vaccination, IVF, in vitro babies — is a history of warnings that proved false, and bioconservatives know they may be reciting that history again. "Repugnance" has been wrong before, which is why the appeal to intuition must be paired with arguments that can survive scrutiny.

The debate is best understood as a division of labor rather than a winner-take-all contest. Transhumanists keep the future open and force us to justify our limits; bioconservatives keep the past close and force us to notice what we are risking. Between them, they define the actual choices that will shape whether, and how, humanity is transformed.

For all the sharpness of the dispute, both sides protect something real. Bioconservatives protect the value of the given — the dignity of ordinary, unenhanced, mortal human life, which enhancement rhetoric can too easily treat as a defect to be fixed. Transhumanists protect the value of relief — the sense that suffering and early death are enemies, not teachers, and that refusing to fight them is its own kind of cruelty.

The most productive readings of the debate refuse to choose between these wholesale. The question is not "enhance or not" but "which enhancements, for whom, decided how?" — and here bioconservatism's insistence on dignity and limits has as much to contribute as transhumanism's insistence on opportunity and progress. The future will not be decided by the slogan either camp prefers, but by the quality of that joint deliberation.

Sources

  • Stanford Encyclopedia of Philosophy: Transhumanism — https://plato.stanford.edu/entries/transhumanism/
  • Fukuyama, Francis, "Our Posthuman Future: Consequences of the Biotechnology Revolution" (Farrar, Straus and Giroux) — https://us.macmillan.com/books/9780374706180/ourposthumanfuture
  • Sandel, Michael J., "The Case Against Perfection: Ethics in the Age of Genetic Engineering" (Harvard University Press) — https://www.hup.harvard.edu/books/9780674032384
Knowledge Network

Archive references

Sources

3 scholarly sources
  • 01
    TranshumanismBy Stanford Encyclopedia of PhilosophyConsult source
  • 02
    Our Posthuman Future: Consequences of the Biotechnology RevolutionBy Francis Fukuyama (Farrar, Straus and Giroux)Consult source
  • 03
    The Case Against Perfection: Ethics in the Age of Genetic EngineeringBy Michael J. Sandel (Harvard University Press)Consult source

ZHAIBIAN Editorial Board reviewed

Reviewed by ZHAIBIAN AI Editorial Review · 2026-08-17

Based on 3 scholarly sourcesLast updated 2026-08-17